Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HTC Interim / Quarterly Report 2017

May 9, 2017

52128_rns_2017-05-09_bdb876b5-9a5d-417d-98c1-4f86af5e5eb4.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

HTC CORPORATION

1Q17 BUSINESS REVIEW

Peter Shen, CFO May 9th, 2017

DISCLAIMER STATEMENT

  • • This presentation and release contain "forward-looking statements" which may include projections of future results of operations, financial condition or business prospects based on our own information and other sources.
  • • Our actual results of operations, financial condition or business prospects may differ from those expressed or implied in these forward-looking statements for a variety of reasons, including but not limited to market demand, price fluctuations, competition, international economic conditions, supply chain issues, exchange rate fluctuations and other risks and factors beyond our control.
  • • The forward-looking statements in this release reflect the current belief of HTC as of the date of this release. HTC undertakes no obligation to update these forward-looking statements for events or circumstances that occur subsequent to such date.

EXECUTIVE SUMMARY

1Q17 Financial Highlights:

  • • Revenue of NT\$14.5 billion with gross margin of 16.3%
  • •Operating loss of NT\$2.4 billion with operating margin of -16.2%
  • •Net loss after tax of NT\$2.0 billion, or -NT\$2.47 per share

Business Update

  • • HTC's continued program of resource realignment and process streamlining resulted in a 20% operating expenses saving and an increase in gross margin of 16.3% over the quarter.
  • • The HTC U Ultra and U Play premium smartphones were launched in January, boasting unique design, adaptive audio and new HTC Sense Companion AI features.
  • • High demand was seen for the HTC VIVE Tracker, which was launched in January and enables developers to easily add functionality for a whole range of accessories into their VR experiences.
  • • As part of the Dynamical Biomarkers Group, HTC's Health research division was awarded first finalist in the prestigious Qualcomm Tricorder XPRIZE to develop a medical diagnostics kit for remote regions.

REVENUES AND OPERATING PROFIT

GROSS AND OPERATING MARGINS

1Q 2017 P&L (CONSOLIDATED)

\$
N
T
b
n
Q
1
1
6
Q
4
1
6
Q
1
1
7
R
E
V
E
N
U
E
S
1
4
8
2
2
2
1
4.
5
G
O
S
S
O
R
P
R
F
I
T
1.
4
2
3
2.
4
O
P
E
R
A
T
I
N
G
E
X
P
E
N
S
E
6.
2
5
9
4.
7
S
A
L
E
S
M
K
T
I
N
G
2
0
2
1
3
1.
S
C
R
E
E
A
R
H
D
E
V
3
0
2
7
2.
6
G
E
N
E
R
A
L
A
D
M
1.
2
1.
1
0.
9
O
P
E
R
A
T
I
N
G
P
R
O
F
I
T
4
8
-
3
6
-
2.
4
-
N
P
B
T
2
5
-
3
3
-
2.
0
-
N
P
A
T
1
2
6
-
3
1
-
2.
0
-
G
R
O
S
S
M
A
R
G
I
N
(
)
%
9
4
%
1
0.
5
%
6.
3
1
%
O
P
E
R
A
T
I
N
G
M
A
R
G
I
N
(
%
)
3
2
4
%
-
1
6.
0
%
-
1
6.
2
%
-
\$
E
P
S
2
(
N
T
)
3
1
6
-
3
7
7
-
2.
4
7
-

1 Attributable to stockholders of parent company, excluding minority interest.

2 EPS was calculated based on number of outstanding shares at that time.

1Q 2017 BALANCE SHEET (CONSOLIDATED)

\$
N
T
b
n
M
3
6
1,
1
a
r
D
3
6
1,
1
e
c
M
3
1,
1
7
a
r
T
O
T
A
L
A
S
S
E
T
S
1
1
9
2
1
0
3
1
9
2.
8
1
C
h
a
s
4
1.
7
3
5
8
3
3.
1
A
R
1
1.
5
1
6.
0
9.
0
I
N
V
E
N
T
O
R
Y
1
9
2
1
4
2
9
1
4.
O
T
H
E
R
A
S
S
E
T
S
4
6.
8
3
7.
1
3
8
5.
T
O
T
A
L
L
I
A
B
I
L
I
T
I
E
S
5
7.
4
5
1.
3
4
4.
8
2
O
Q
T
T
A
L
E
U
I
T
Y
6
1.
8
5
1.
8
4
8.
0
3
M
E
T
R
I
C
S
S
S
S
O
S
G
D
A
Y
A
L
E
U
T
T
A
N
D
I
N
1
1
1
8
0
9
6
I
N
V
E
N
T
O
R
Y
T
U
R
N
O
V
E
R
D
A
Y
S
1
4
9
9
2
3
1
7
D
A
Y
S
P
A
Y
A
B
L
E
O
U
T
S
T
A
N
D
I
N
G
1
8
8
1
2
8
8
1
7
  1. Includes time deposits with original maturities more than 3 months

  2. Attributable to stockholders of parent company, excluding minority interest.

  3. Financial metrics are calculated based on quarterly numbers, starting from 2Q 2012

CONSOLIDATED BALANCE SHEETS (In Thousands of New Taiwan Dollars)

ASSETS
Amount
%
Amount
%
Amount
%
CURRENT ASSETS
Cash and cash equivalents (Note 6)
\$ 26,565,598
29
\$ 30,080,217
29
\$ 39,031,628
33
Financial assets at fair value through profit or loss - current (Notes 7 and 31)
77,332
-
143,642
-
127,521
-
Available-for-sale financial assets - current (Note 31)
236,144
-
199,344
-
249,575
-
Derivative financial assets for hedging - current (Notes 8 and 31)
-
-
-
-
1,100
-
Debt investments with no active market - current (Note 31)
7,582
-
8,067
-
8,069
-
Trade receivables, net (Notes 11 and 32)
9,046,951
10
15,961,835
15
11,525,883
10
Other receivables (Note 11)
231,759
-
168,526
-
645,546
1
Current tax assets
137,458
-
184,817
-
172,703
-
Inventories (Note 12)
14,923,347
16
14,163,571
14
19,210,735
16
Prepayments (Note 13)
1,593,590
2
1,833,499
2
3,726,028
3
Non-current assets held for sale (Note 14)
1,563,732
2
-
-
-
-
Other current financial assets (Notes 10 and 33)
6,576,255
7
5,750,450
6
2,684,493
2
Other current assets
70,367
-
68,414
-
76,504
-
Total current assets
61,030,115
66
68,562,382
66
77,459,785
65
NON-CURRENT ASSETS
Available-for-sale financial assets - non-current (Note 31)
96
-
86
-
86
-
Financial assets measured at cost - non-current (Notes 9 and 31)
3,266,107
3
3,363,736
3
3,330,763
3
Debt investments with no active market (Note 31)
29,570
-
25,009
-
-
-
Investments accounted for using equity method (Note 16)
466,341
-
531,445
1
211,122
-
Property, plant and equipment (Note 17)
11,712,682
13
12,025,496
12
14,943,270
13
Investment properties, net (Note 18)
-
-
1,527,001
1
1,680,709
2
Intangible assets (Note 19)
3,316,074
4
3,878,356
4
5,022,059
4
Deferred tax assets
8,996,321
10
8,957,876
9
8,735,824
7
Refundable deposits (Note 31)
1,360,583
1
1,501,480
1
1,617,463
1
Long-term receivables (Note 11)
-
-
-
-
1,472,529
1
Net defined benefit asset - non-current
45,231
-
40,439
-
81,201
-
Other non-current assets (Note 13)
2,568,848
3
2,735,876
3
4,623,867
4
Total non-current assets
31,761,853
34
34,586,800
34
41,718,893
35
TOTAL
\$ 92,791,968
100
\$ 103,149,182
100
\$ 119,178,678
100
LIABILITIES AND EQUITY
CURRENT LIABILITIES
Short-term borrowings (Note 20)
\$
2,756,560
3
\$
-
-
\$
-
-
Financial liabilities at fair value through profit or loss - current (Notes 7 and 31)
194,631
-
133,420
-
264,718
-
Derivative financial liability for hedging - current (Notes 8 and 31)
12,110
-
-
-
3,309
-
Note and trade payables (Notes 21 and 32)
21,109,467
23
26,247,728
26
25,778,172
22
Other payables (Notes 22 and 32)
13,569,654
15
18,348,734
18
21,597,135
18
Current tax liabilities
143,595
-
155,651
-
136,316
-
Provisions - current (Note 23)
3,143,478
3
3,384,311
3
5,298,140
4
Other current liabilities (Notes 14 and 22)
3,747,735
4
3,004,432
3
3,032,395
3
Total current liabilities
44,677,230
48
51,274,276
50
56,110,185
47
NON-CURRENT LIABILITIES
Deferred tax liabilities
85,823
-
81,294
-
79,057
-
Guarantee deposits received (Note 31)
6,289
-
22,106
-
27,613
-
Other non-current liabilities (Notes 14 and 22)
-
-
-
-
1,210,369
1
March 31, 2017
(Reviewed)
December 31, 2016
(Audited)
March 31, 2016
(Reviewed)
Total non-current liabilities 92,112 - 103,400 - 1,317,039 1
Total liabilities 44,769,342 48 51,377,676 50 57,427,224 48
EQUITY (Note 24)
Share capital - ordinary shares 8,219,042 9 8,220,087 8 8,276,415 7
Capital surplus 15,626,493 17 15,614,641 15 15,487,941 13
Retained earnings
Legal reserve 18,297,655 20 18,297,655 18 18,297,655 15
Unappropriated earnings 8,808,880 9 10,841,425 10 19,077,139 16
Other equity (2,929,444) (3) (1,202,302) (1) 612,304 1
Total equity 48,022,626 52 51,771,506 50 61,751,454 52
TOTAL \$ 92,791,968 100 \$ 103,149,182 100 \$ 119,178,678 100

The accompanying notes are an integral part of the consolidated financial statements.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In Thousands of New Taiwan Dollars, Except Loss Per Share) (Reviewed, Not Audited)

For the Three Months Ended March 31
2017 2016
Amount % Amount %
OPERATING REVENUES (Notes 25 and 32) \$ 14,530,823 100 \$ 14,820,982 100
OPERATING COST (Notes 12, 26 and 32) 12,167,637 84 13,433,886 90
GROSS PROFIT 2,363,186 16 1,387,096 10
OPERATING EXPENSES (Notes 26 and 32)
Selling and marketing
General and administrative
Research and development
Total operating expenses
1,271,023
875,376
2,574,388
4,720,787
9
6
17
32
1,984,328
1,248,618
2,957,261
6,190,207
13
9
20
42
OPERATING LOSS (2,357,601) (16) (4,803,111) (32)
NON-OPERATING INCOME AND EXPENSES
Other income (Note 26)
Other gains and losses (Notes 8, 14 and 26)
Finance costs
Share of the profit or loss of associate and joint
venture (Note 16)
272,189
81,531
(2,467)
(34,392)
2
-
-
-
237,979
2,101,768
(4,235)
(28,362)
1
14
-
-
Total non-operating income and expenses 316,861 2 2,307,150 15
LOSS BEFORE INCOME TAX (2,040,740) (14) (2,495,961) (17)
INCOME TAX BENEFIT (EXPENSE) (Note 27) 8,195 - (120,486) (1)
LOSS FOR THE PERIOD (2,032,545) (14) (2,616,447) (18)
OTHER COMPREHENSIVE LOSS, NET OF
INCOME TAX
Items that may be reclassified subsequently to profit
or loss:
Exchange differences on translating foreign
operations
(1,805,815) (12) (434,730) (3)
Unrealized gain (loss) on available-for-sale
financial assets
50,044 - (103,724) -
Cash flow hedge (12,882) - (2,627) -

(Continued)

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In Thousands of New Taiwan Dollars, Except Loss Per Share) (Reviewed, Not Audited)

For the Three Months Ended March 31
2017 2016
Amount % Amount %
Other comprehensive loss for the period, net of
income tax
\$
(1,768,653)
(12) \$
(541,081)
(3)
TOTAL COMPREHENSIVE LOSS FOR THE
PERIOD
\$
(3,801,198)
(26) \$
(3,157,528)
(21)
NET LOSS ATTRIBUTABLE TO
Owners of the parent
\$
(2,032,545)
(14) \$
(2,616,447)
(18)
TOTAL COMPREHENSIVE LOSS ATTRIBUTABLE
TO
Owners of the parent
\$
(3,801,198)
(26) \$
(3,157,528)
(21)
LOSS PER SHARE (Note 28)
Basic
\$
(2.47)
\$
(3.16)

The accompanying notes are an integral part of the consolidated financial statements. (Concluded)

CONSOLIDATED STATEMENTS OF CASH FLOWS (In Thousands of New Taiwan Dollars) (Reviewed, Not Audited)

For the Three Months Ended
March 31
2017 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Loss before income tax \$
(2,040,740)
\$
(2,495,961)
Adjustments for:
Depreciation expense 275,763 520,531
Amortization expense 355,370 505,104
Finance costs 2,467 4,235
Interests income (75,181) (123,227)
Dividend income (7,420) (78,453)
Compensation cost of employee share-based payments 52,318 116,887
Share of the loss of associate and joint venture 34,392 28,362
Net loss (gain) on disposal of property, plant and equipment 129 (2,089,417)
Impairment loss on non-financial assets 1,385,920 471,594
Ineffective portion of cash flow hedges (772) (418)
Changes in operating assets and liabilities
Decrease in financial instruments held for trading 127,521 196,146
Decrease in trade receivables 6,914,884 6,993,065
Increase in other receivables (59,561) (171,290)
Increase in inventories (2,145,696) (558,692)
Decrease in prepayments 239,909 674,940
(Increase) decrease in other current assets (1,953) 18,107
Decrease in other non-current assets 43,312 132,152
Decrease in note and trade payables (5,138,261) (3,820,213)
Decrease in other payables (4,767,172) (3,560,887)
Decrease in provisions (240,833) (694,118)
Decrease in other current liabilities (644,940) (657,368)
Increase in other operating liabilities - 1,210,369
Cash used in operations (5,690,544) (3,378,552)
Interest received 71,509 100,982
Interest paid (2,467) (4,235)
Income tax paid (12,612) (174,064)
Net cash used in operating activities (5,634,114) (3,455,869)
CASH FLOWS FROM INVESTING ACTIVITIES
Payments to acquire debt investment with no active market (6,139) -
Payments to acquire financial assets measured at cost (68,372) -
Proceeds from disposal of non-current assets held for sale - 6,060,000
Payments for property, plant and equipment (30,705) (125,449)
Proceeds from disposal of property, plant and equipment 1,384 28,095
Increase in advance receipts - disposal of property 1,388,243 -
Increase in refundable deposits - (37,121)
Decrease in refundable deposits 140,897 -
(Continued)

CONSOLIDATED STATEMENTS OF CASH FLOWS (In Thousands of New Taiwan Dollars) (Reviewed, Not Audited)

For the Three Months Ended
March 31
2017 2016
Payments for intangible assets
(Increase) decrease in other current financial assets
Dividends received
\$
-
(825,805)
7,420
\$
(72,763)
1,415,797
23,537
Net cash generated from investing activities 606,923 7,292,096
CASH FLOWS FROM FINANCING ACTIVITIES
Increase in short-term borrowings
Refund of guarantee deposits received
Net cash generated from (used in) financing activities
2,756,560
(15,817)
2,740,743
-
(2,546)
(2,546)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH
EQUIVALENTS
(1,228,171) (148,852)
NET (DECREASE) INCREASE IN CASH AND CASH
EQUIVALENTS
(3,514,619) 3,684,829
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 30,080,217 35,346,799
CASH AND CASH EQUIVALENTS, END OF PERIOD \$ 26,565,598 \$ 39,031,628

The accompanying notes are an integral part of the consolidated financial statements. (Concluded)